In Vitro and In Silico Analysis of Bergenia ciliata and Mimosa pudica for Inhibition of α-Amylase
The discovery of antidiabetic natural products is a flourishing field of opportunity in the sector of drug discovery. Various medicinal plants with diverse chemical constituents have been extensively studied for drug development. Bergenia ciliata and Mimosa pudica have been traditionally used for th...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Journal of Chemistry |
| Online Access: | http://dx.doi.org/10.1155/2022/6997173 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832549259825643520 |
|---|---|
| author | Mahesh Bohara Sajani Ghaju Kabita Sharma Surya Kant Kalauni Karan Khadayat |
| author_facet | Mahesh Bohara Sajani Ghaju Kabita Sharma Surya Kant Kalauni Karan Khadayat |
| author_sort | Mahesh Bohara |
| collection | DOAJ |
| description | The discovery of antidiabetic natural products is a flourishing field of opportunity in the sector of drug discovery. Various medicinal plants with diverse chemical constituents have been extensively studied for drug development. Bergenia ciliata and Mimosa pudica have been traditionally used for the treatment of diabetes and consist of valuable phytochemicals. In this study, we have analyzed total phenolic and flavonoid content along with the antioxidant and α-amylase inhibitory activity. The crude extract of B. ciliata contains higher levels of TPC whereas higher TFC was observed in M. pudica. The strong antioxidant activity was shown by B. ciliata with an IC50 value of 125.86 ± 4.16 μg/mL. The ethyl acetate extract of B. ciliata and M. pudica showed higher α-amylase inhibitory activity with an IC50 value of 13.97 ± 0.10 and 11.97 ± 0.36 μg/mL, respectively. The biological potential of the reported phytochemicals was also assessed by using bioinformatic tools. Furthermore, the active phytochemicals from these plants were docked with human pancreatic α-amylase to study their inhibitory activities to this enzyme. The docking analysis revealed that catechin has lower binding energy (−8.6 kcal/mol) as compared to the commercial drug acarbose (−7.3 kcal/mol) indicating higher affinity towards the enzyme. This study additionally sheds more light on medicinal plants’ antidiabetic activity. So, this study will aid in the investigation of the biological properties of these plants as well as the identification of potential compounds with antidiabetic properties. |
| format | Article |
| id | doaj-art-bce6d804110947ef9039bdeb5419390c |
| institution | Kabale University |
| issn | 2090-9071 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Chemistry |
| spelling | doaj-art-bce6d804110947ef9039bdeb5419390c2025-02-03T06:11:53ZengWileyJournal of Chemistry2090-90712022-01-01202210.1155/2022/6997173In Vitro and In Silico Analysis of Bergenia ciliata and Mimosa pudica for Inhibition of α-AmylaseMahesh Bohara0Sajani Ghaju1Kabita Sharma2Surya Kant Kalauni3Karan Khadayat4Central Department of ChemistryDepartment of BiotechnologyCentral Department of ChemistryCentral Department of ChemistryCentral Department of ChemistryThe discovery of antidiabetic natural products is a flourishing field of opportunity in the sector of drug discovery. Various medicinal plants with diverse chemical constituents have been extensively studied for drug development. Bergenia ciliata and Mimosa pudica have been traditionally used for the treatment of diabetes and consist of valuable phytochemicals. In this study, we have analyzed total phenolic and flavonoid content along with the antioxidant and α-amylase inhibitory activity. The crude extract of B. ciliata contains higher levels of TPC whereas higher TFC was observed in M. pudica. The strong antioxidant activity was shown by B. ciliata with an IC50 value of 125.86 ± 4.16 μg/mL. The ethyl acetate extract of B. ciliata and M. pudica showed higher α-amylase inhibitory activity with an IC50 value of 13.97 ± 0.10 and 11.97 ± 0.36 μg/mL, respectively. The biological potential of the reported phytochemicals was also assessed by using bioinformatic tools. Furthermore, the active phytochemicals from these plants were docked with human pancreatic α-amylase to study their inhibitory activities to this enzyme. The docking analysis revealed that catechin has lower binding energy (−8.6 kcal/mol) as compared to the commercial drug acarbose (−7.3 kcal/mol) indicating higher affinity towards the enzyme. This study additionally sheds more light on medicinal plants’ antidiabetic activity. So, this study will aid in the investigation of the biological properties of these plants as well as the identification of potential compounds with antidiabetic properties.http://dx.doi.org/10.1155/2022/6997173 |
| spellingShingle | Mahesh Bohara Sajani Ghaju Kabita Sharma Surya Kant Kalauni Karan Khadayat In Vitro and In Silico Analysis of Bergenia ciliata and Mimosa pudica for Inhibition of α-Amylase Journal of Chemistry |
| title | In Vitro and In Silico Analysis of Bergenia ciliata and Mimosa pudica for Inhibition of α-Amylase |
| title_full | In Vitro and In Silico Analysis of Bergenia ciliata and Mimosa pudica for Inhibition of α-Amylase |
| title_fullStr | In Vitro and In Silico Analysis of Bergenia ciliata and Mimosa pudica for Inhibition of α-Amylase |
| title_full_unstemmed | In Vitro and In Silico Analysis of Bergenia ciliata and Mimosa pudica for Inhibition of α-Amylase |
| title_short | In Vitro and In Silico Analysis of Bergenia ciliata and Mimosa pudica for Inhibition of α-Amylase |
| title_sort | in vitro and in silico analysis of bergenia ciliata and mimosa pudica for inhibition of α amylase |
| url | http://dx.doi.org/10.1155/2022/6997173 |
| work_keys_str_mv | AT maheshbohara invitroandinsilicoanalysisofbergeniaciliataandmimosapudicaforinhibitionofaamylase AT sajanighaju invitroandinsilicoanalysisofbergeniaciliataandmimosapudicaforinhibitionofaamylase AT kabitasharma invitroandinsilicoanalysisofbergeniaciliataandmimosapudicaforinhibitionofaamylase AT suryakantkalauni invitroandinsilicoanalysisofbergeniaciliataandmimosapudicaforinhibitionofaamylase AT karankhadayat invitroandinsilicoanalysisofbergeniaciliataandmimosapudicaforinhibitionofaamylase |